Literature DB >> 11803236

Cognitive dysfunction in recovered depressive patients with silent cerebral infarction.

H Yamashita1, T Fujikawa, I Yanai, S Morinobu, S Yamawaki.   

Abstract

In this study, we characterized cognitive functioning in patients with major depression and silent cerebral infarction (SCI), as detected by magnetic resonance imaging (MRI), after they had recovered from depression. Thirty-five patients with unipolar depression who experienced the onset of depression after the age of 50 underwent MRI and were classified as SCI(+) (n = 17) or SCI(-) (n = 18). The Wechsler Adult Intelligence Scale-Revised (WAIS-R) and the Uchida-Kraepelin psychodiagnostic test were administered after the patients had recovered from depression. In addition, the intelligence quotient (IQ) and mental speed of the patients in the two groups were compared. The total, verbal and performance IQ scores, as determined by the WAIS-R, were significantly lower in the SCI(+) group than in the SCI(-) group. The mental speed of patients in the SCI(+) group, as assessed by the Uchida-Kraepelin psychodiagnostic test, was almost half that of the SCI(-) group. Our findings provide further evidence that a comprehensive impairment of cognitive functioning, especially a severe reduction in mental speed, remains after recovery from depression in patients with major depression and SCI. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11803236     DOI: 10.1159/000048667

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  2 in total

Review 1.  Incidence and Risk Factors for Silent Brain Infarction After On-Pump Cardiac Surgery: A Meta-analysis and Meta-regression of 29 Prospective Cohort Studies.

Authors:  Jingfei Guo; Chenghui Zhou; Liu Yue; Fuxia Yan; Jia Shi
Journal:  Neurocrit Care       Date:  2021-04       Impact factor: 3.210

Review 2.  The epidemiology of silent brain infarction: a systematic review of population-based cohorts.

Authors:  Jonathon P Fanning; Andrew A Wong; John F Fraser
Journal:  BMC Med       Date:  2014-07-09       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.